What question did this study set out to answer?

Evaluate the clinical validity and utility of B-type natriuretic peptide (BNP) measurements in diagnosing, predicting prognosis, and guiding therapeutic monitoring for heart failure in primary care.

July 1, 2003The Journal of the American Board of Family MedicineOpen Access

B-type Natriuretic Peptide: A Review of Its Diagnostic, Prognostic, and Therapeutic Monitoring Value in Heart Failure for Primary Care Physicians

View Full Paper

Ask AI

Bookmark

Why the study?

Does B-type natriuretic peptide (BNP) measurement provide diagnostic, prognostic, and therapeutic monitoring value in patients with heart failure?

Population

Patients with heart failure or suspected heart failure

Design

Review

Authors

RCRoberto CardarelliBaptist Health Louisville TLT. G. LumicaoBaylor College of Medicine

Discussion

Member takes

Implication

Supports BNP use for HF diagnosis and monitoring in primary care; leaves open confirmation of outcome benefits in prospective trials.

Key Points

Evaluate the clinical validity and utility of B-type natriuretic peptide (BNP) measurements in diagnosing, predicting prognosis, and guiding therapeutic monitoring for heart failure in primary care.
Conducted a comprehensive literature search across MEDLINE (1966–present), CINAHL (1980–present), and Evidence-Based Medicine Reviews.
Used search queries including 'cardiac neuro-hormone,' 'B-type natriuretic peptide,' and 'congestive heart failure' to identify relevant diagnostic, prognostic, and therapeutic management studies.
A BNP concentration threshold of 80 pg/mL assists in diagnosing heart failure in symptomatic patients without prior heart failure history.
Maintaining a target BNP concentration of less than 100 pg/mL correlates with functional improvement and a reduction in clinical endpoints such as cardiovascular death.
BNP levels rise proportionally with heart failure severity, making individual baseline tracking useful for titrating medical therapy to reduce morbidity and mortality.

Structured PICO

Does B-type natriuretic peptide (BNP) measurement provide diagnostic, prognostic, and therapeutic monitoring value in patients with heart failure?

Population

Patients with heart failure or suspected heart failure

Intervention

B-type natriuretic peptide (BNP) measurement

Outcome

Diagnostic, prognostic, and therapeutic monitoring value of BNPsurrogate

BNP measurement is a useful biomarker for diagnosing heart failure in symptomatic patients and monitoring therapeutic response.

Limitations

Larger studies are needed to support further recommendations

Cite This Study

Cardarelli et al. (2003) studied this question.

synapsesocial.com/papers/6a7ceced7ef24e040aa564ff https://doi.org/10.3122/jabfm.16.4.327

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

B-type Natriuretic Peptide: A Review of Its Diagnostic, Prognostic, and Therapeutic Monitoring Value in Heart Failure for Primary Care Physicians

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Topics

B-type Natriuretic Peptide: A Review of Its Diagnostic, Prognostic, and Therapeutic Monitoring Value in Heart Failure for Primary Care Physicians

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider